Article info

Download PDFPDF
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus

Authors

  1. Correspondence to Dr Ali Sobhy, Clinical Pathology Department, Faculty of Medicine, Al-Azhar University, Assiut branch; dralisobhy{at}azhar.edu.eg
View Full Text

Citation

Sobhy A, Fakhry M. M, A Azeem H, et al
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus

Publication history

  • Accepted September 15, 2018
  • First published October 31, 2018.
Online issue publication 
February 25, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.